FIELD: medicine.
SUBSTANCE: blood serum is analysed for promoter region methylation of GSTP, p16 and N33 genes by methyl-sensitive PCR method. If observing abnormal methylation at least in two of said genes, the presence of a disease is concluded.
EFFECT: higher accuracy of early DNA-diagnosis of prostate cancer ensured by the use blood serum DNA to be analysed, technique exhibits higher specificity due to the correct gene specification in a test system and allows applying profit-proved detection methods.
1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETECTION OF MOLECULAR-GENETIC MARKERS ASSOCIATED WITH BARRETT ESOPHAGUS PROGRESSION | 2016 |
|
RU2635964C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR PROSTATE CANCER | 2012 |
|
RU2521389C2 |
METHOD FOR EARLY DIAGNOSIS OF PROSTATE TUMORS | 2021 |
|
RU2756643C1 |
DIAGNOSTIC TECHNIQUE FOR PROSTATE CANCER | 2011 |
|
RU2464574C1 |
METHOD FOR DIAGNOSTICS OF PROSTATE ONCOLOGICAL DISEASES | 2007 |
|
RU2348042C1 |
METHOD FOR FORMATION OF DNA METHYLATION MARKER SYSTEMS | 2011 |
|
RU2472859C1 |
METHOD FOR PREDICTING ONCOLOGICAL DISEASES | 2004 |
|
RU2245551C1 |
METHOD FOR DIAGNOSING METASTASES OF COLON CANCER | 2016 |
|
RU2647470C2 |
DIAGNOSTIC TECHNIQUE FOR PROSTATE CANCER | 2015 |
|
RU2607949C1 |
METHOD OF PERSONALIZATION OF MEDICAL CARE FOR PATIENTS WITH STOMACH CANCER | 2019 |
|
RU2713907C1 |
Authors
Dates
2010-12-10—Published
2009-07-06—Filed